Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish
Farmovs
In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19. 

The trial is expected to include more than 45 countries worldwide, including a number of South African sites. 

Farmovs

FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.   

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients. 

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.  FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.


News Archive

Lecturer’s debut novel wins ATKV Prize for Fiction
2015-10-14

Dr Francois Smith
Photo: Johan Roux

Kamphoer made its debut on the literary scene just over a year ago, and on 11 September 2015, it was declared the best novel by the Afrikaanse Taal en Kultuurvereniging (ATKV). This is not the first time Kamphoer has been recognised as literary gem. Earlier this year, the novel was shortlisted for the W A Hofmeyr Prize as well as the Huisgenoot Tempo Award.

Dr Francois Smith, the author, joined the University of the Free State (UFS) as a lecturer in the Department of Afrikaans and Dutch, German and French at the beginning of this year. Prior to entering the academic sphere, he dedicated about 11 years of his life to editing for a publishing house. Certainly, helping other people write and produce books thoroughly prepared him for authorship.

For three months, Smith spent eight hours a day creating his award-winning masterpiece. The secret of success lies in the ABC formula. “The ABC for writing is Apply Back to Chair. You have to go and sit down and start typing,” he says.

That is when passion meets imagination, albeit at times, one might also need inspiration. Smith applied this winning formula meticulously, and it has resulted in over 30 000 copies of Kamphoer being sold since July 2014.

He was taken aback by the novel’s warm reception. “I wrote a book, finished it, and knew that it wasn’t bad but I never for one moment imagined that it would be such a big commercial success,” he said.

About Kamphoer

The book which Smith describes as a good but not an easy read about a disturbing subject is the true story of a woman who was brutally raped during the South African War and left for dead.  After the traumatic experience, she dedicates her life to helping others deal with similar ordeals, re-encountering her rapists in the process.

About the award

Kamphoer emerged as an exceptional contribution amongst two other finalists. Kerneels Breytenbach’s Ester as well as Harry Kalmer’s ’n Duisend stories oor Johannesburg were also competing for the prestigious award.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept